Device Trial Radar · NCT04816591
Middle Meningeal Artery Embolization for the Treatment of Subdural Hematomas With TRUFILL® n-BCA
Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
376
Actual
Start
May 27, 2021
Primary completion
Aug 15, 2024
Study completion Mar 26, 2025
Sponsor
- Lead sponsor
- Cerenovus, Part of DePuy Synthes Products, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 25, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective, multi-center, open-label, randomized controlled study in which subjects can receive standard of care (SOC) alone or SOC and TRUFILL n-BCA MMA embolization for the treatment of chronic subdural hematomas (cSDH).
Conditions
- Chronic Subdural Hematoma
Interventions
Experimental: Interventional Cohort: TRUFILL n-Butyl Cyanoacrylate (n-BCA) Liquid Embolic SystemDevice
Standard of Care Surgery + Embolization
Standard of Care SurgeryOther
Standard of Care Surgery Only
Experimental: Interventional Cohort: TRUFILL n-BCA Liquid Embolic SystemDevice
Standard of Care Medical Management + Embolization
Standard of Care Medical ManagementOther
Standard of Care Medical Management Only
Primary outcomes
What the sponsor says the trial is designed to measure.
- Residual or Re-accumulation of the Chronic Subdural Hematoma (cSDH) (Greater Than [>] 10 Millimeter [mm]) as Assessed by an Independent Core Laboratory OR Any Re-operation or Surgical Procedure on the cSDH at 6 MonthsTime frame: At 6 months
- Percentage of Participants With All Adverse Events (AEs)Time frame: From randomization up to 6 months
Locations
33 sites in 2 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Carondelet St Joseph's Hospital
Tucson, Arizona
John Muir Physician Network Clinical Research Center
Walnut Creek, California
30 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.